Phase finalization is where formulation theory meets the physical reality of a shippable product. Every line in the protocol now exists to defend a single claim: that the matrix you receive in early 2026 is identical, vial-to-vial, to the one validated under lab conditions.
We are currently in the final stability arc before our priority drop. Three production-equivalent batches have been pulled, sealed, and placed under accelerated aging conditions to simulate twelve months of real-world storage.
Inputs are locked under one supplier per ingredient. Order of addition, temperature curves, and dwell times are documented and signed off. Glass spec, closure torque, and oxygen ingress have been profiled to the milligram.
The early 2026 priority drop is intentionally small. It is allocated to people who joined before the public listing because their feedback closes our loop on real-world taste, ritual fit, and felt effect across more days than a lab can simulate.